Characteristics and features of bone turnover in rheumatoid arthritis patients with osteoporosis

Main Article Content

Orest Abrahamovych
Ulyana Abrahamovych
Viktoriia Chemes
Oksana Fayura


Rheumatoid arthritis (RA) is a systemic autoimmune disease with a chronic inflammatory process that negatively affects bone metabolism, leading to a violation of bone mineral density (BMD). Bone remodeling markers are important indicators of the state of bone tissue that can provide additional important information for the clinician about BMD disorders. The patients were randomly enrolled in the study with preliminary stratification by the presence of RA as well as the criteria of the American College of Rheumatology and the European League Against Rheumatism in 2010, also normal bone mineral density (BMD) and osteoporosis (OP) were diagnosed by ultrasound bone densitometry. The study included 42 patients (33 women (78,57 %) and 9 men (21,43 %)) aged 38 to 60 years. The control group consisted of 22 healthy individuals of (18 women (81.81 %) and 4 men (18.19 %) with no BMD disorders. Markers of bone formation, osteocalcin (OC), P1NP and bone resorption β-CrossLaps were studied. Based on the results, it can be concluded that the serum content of both OC and P1NP is significantly lower, while β-CrossLaps is slightly higher in RA patients with OP compared to healthy individuals. Also, OC and P1NP in the blood serum is significantly lower in RA patients with OP compared with RA patients with normal BMD, and the content of β-CrossLaps did not have a significant difference in RA patients with OP compared with RA patients with normal BMD. In rheumatoid arthritis patients with OP, bone mineral density disorder is marked by a decrease in bone formation and an increase in resorption processes.

Google Scholar





Index Copernicus

Semantic Scholar

Article Details

How to Cite
Abrahamovych, O., Abrahamovych, U., Chemes, V., & Fayura, O. (2023). Characteristics and features of bone turnover in rheumatoid arthritis patients with osteoporosis. Scientific Collection «InterConf+», (33(155), 230–235.


Radu AF, Bungau SG. Management of Rheumatoid Arthritis: An Overview. Cells. 2021;10(11):2857. DOI:

Lin YC, Li YH, Chang CH, Hu CC, Chen DW, Hsieh PH et al. Rheumatoid arthritis patients with hip fracture: a nationwide study. Osteoporos

Int. 2015;26(2):811-817. DOI:

Barco CMR, Arija SM, Pérez MR. Biochemical Markers in Osteoporosis: Usefulness in Clinical Practice. Reumatol Clin. 2012;8(3):149-152. DOI:

Order of the Ministry of Health of Ukraine № 676 dated 12.10.2006 On approval of medical care protocols in the specialty "Rheumatology")


Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology. 2012;51(6):vi5-vi9. DOI:

Abrahamovych UO, Abrahamovych OO, Tsyhanyk LV, Synenkyi OV, Guta SI. Сomparative evaluation of bone mineral density based upon the results of ultrasound osteodensitometry, X-ray Osteodensitometry, and dualenergy X-ray Absorptiometry tests in premenopausal women with systemic lupus erythematosus. Lviv Clinical Bulletin. 2017;1(17):32-37) (Ukrainian) lkv2017.01.032 DOI:

Annapoorna N, Venkateswara Rao G, Reddy NS, Rambabu P, Samabasiva Ra KRS. An Increased Risk of Osteoporosis during Acquired

Immunodeficiency Syndrome. Int J Med Sci. 2004;1(3):152-164.